Medela’s portable medical devices offer alternative to piped vacuum systems

Medela Healthcare mobile suction devices can help expand critical care capacity and support hospitals in the fight against COVID-19.

Used worldwide, the company’s portable medical suction machines are designed to provide suction and fluid removal during respiratory treatment provided with ventilators.

Traditionally, hospitals ensure a patient’s airway is clear by utilising suction that relies on central wall piped vacuum. However, guidance published by the National Health Service (NHS) advises hospitals against using piped vacuum to support infectious disease units (IDU) to reduce the risk of virus spread and cross-contamination. 

A previous study looking at contamination rates for wall-mounted suction units discovered contamination on over 30 per cent of devices. Hence, portable medical suction machines are recommended for COVID-19 care. Medela offers a range of portable suction pumps which are available with a virus filter capable of reducing cross-contamination from COVID-19 with filtration efficiency of greater than 99.99987%. 

These compact devices offer flexibility while reducing the risk of viral transmission. When used with disposable collection systems, portable suction machines reduce staff exposure to hazardous fluids, while devices equipped with virus filters further reduce risk of cross-contamination and viral exposure to staff. 

Rob Rennel, Business Unit Manager at Medela said: “Medela’s range of portable medical surgical and airway suction devices facilitate the removal of lung secretions in the inflammatory process of coronavirus – offering life-saving support to critical care patients, while mitigating risks facing staff on the frontlines.”

While most patients with COVID-19 recover over time without the need for special treatment, in more critical cases the infection can trigger pneumonia, causing the lungs to become more inflamed and fill with fluid. Research shows approximately 14% of COVID-19 patients require hospitalisation and oxygen support, while a further 5% require admission to an Intensive Care Unit (ICU) and supportive therapies such as intubation and ventilation.